Lacroix Marc, Toillon Robert-Alain, Leclercq Guy
Laboratoire Jean-Claude Heuson de Cancérologie Mammaire, Institut Jules Bordet - Université Libre de Bruxelles, 127 boulevard de Waterloo, B-1000 Bruxelles, Belgium.
Endocr Relat Cancer. 2006 Jun;13(2):293-325. doi: 10.1677/erc.1.01172.
p53 plays a key role in mediating cell response to various stresses, mainly by inducing or repressing a number of genes involved in cell cycle arrest, senescence, apoptosis, DNA repair, and angiogenesis. According to this important function, p53 activity is controlled in a very complex manner, including several auto-regulatory loops, through the intervention of dozens of modulator proteins (the 'p53 interactome'). p53 mutations are observed in a significant minority of breast tumours. In the remaining cases, alterations of interactome components or target genes could contribute, to some extent, to reduce the ability of p53 to efficiently manage stress events. While the prognostic and predictive value of p53 is still debated, there is an increasing interest for p53-based therapies. The present paper aims to provide updated information on p53 regulation and function, with specific interest on its role in breast cancer.
p53在介导细胞对各种应激的反应中起关键作用,主要是通过诱导或抑制许多参与细胞周期停滞、衰老、凋亡、DNA修复和血管生成的基因。根据这一重要功能,p53的活性以非常复杂的方式受到控制,包括几个自调节环,通过数十种调节蛋白(“p53相互作用组”)的干预。在少数乳腺癌中观察到p53突变。在其余病例中,相互作用组成分或靶基因的改变可能在一定程度上有助于降低p53有效应对应激事件的能力。虽然p53的预后和预测价值仍存在争议,但基于p53的疗法越来越受到关注。本文旨在提供有关p53调节和功能的最新信息,特别关注其在乳腺癌中的作用。